Drug Database
IV
ivosidenib
✓ ApprovedAgios Pharmaceuticals, Inc. · Companion diagnostic · Companion diagnostic
What is ivosidenib?
ivosidenib is a companion diagnostic developed by Agios Pharmaceuticals, Inc.. It is approved for therapeutic indications via others.
Drug Profile
| Company | Agios Pharmaceuticals, Inc. |
| Drug Class | Companion diagnostic |
| Route | Others |
| Status | Approved |
Therapeutic Indications
ivosidenib is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Uterine cancer | ✓ Approved |
Related Research Articles
Unable to load articles right now.